China Monogenic Diabetes Registry
Recruiting · NCT07492004 · Observational (researchers observe without assigning treatment) · Lead sponsor: Tianjin Medical University General Hospital
View the official record on ClinicalTrials.gov →Interventions studied
No Interventions
What this trial is about
This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Diabetes diagnosed before 25 years of age; OR diabetes diagnosed before 35 years of age with ≥1 first-degree relative (parent, sibling, or offspring) diagnosed with diabetes before 40 years of age
- Body mass index (BMI) at diagnosis 28 kg/m²
- Negative glutamic acid decarboxylase antibody (GAD-Ab)
Exclusion criteria
- Secondary diabetes
- Active malignancy or history of malignant tumor within the past 5 years
Where it is running
1 location listed.
- Tianjin medical university general hospital - Tianjin, China